Burow Kristina's Form 4 filing
Neumora Therapeutics, Inc. (NMRA) · filed Nov 13, 2023
- Accession no.
- 0001062993-23-020714
- Filed
- Nov 13, 2023
- Trade date
- Nov 8-10, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market purchases total $1.54M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burow KristinaCIK 0001569248 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2023 | Common Stock | PPurchaseAcquired | +69,127 | $10.78 | +$745,189.06 | 4,024,719 | Indirect | |
| Nov 8, 2023 | Common Stock | PPurchaseAcquired | +23,124 | $11.79 | +$272,631.96 | 4,047,843 | Indirect | |
| Nov 9, 2023 | Common Stock | PPurchaseAcquired | +31,079 | $10.53 | +$327,261.87 | 4,078,922 | Indirect | |
| Nov 10, 2023 | Common Stock | PPurchaseAcquired | +11,844 | $11.37 | +$134,666.28 | 4,090,766 | Indirect | |
| Nov 10, 2023 | Common Stock | PPurchaseAcquired | +5,431 | $11.75 | +$63,814.25 | 4,096,197 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.